Yongjun Liu

Jinan, 250100, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Mechanistic Elucidation of BBOX-Catalyzed Hydroxylation and THP-Induced Oxidative Rearrangement via QM/MM Calculations.

Mechanistic Elucidation of BBOX-Catalyzed Hydroxylation and THP-Induced Oxidative Rearrangement via QM/MM Calculations.

Journal: Molecules (Basel, Switzerland)

Published: April 03, 2026

Temperature-Sensitive Nano-GOx Combined with Downregulation of Tumor Stemness to Initiate Robust Antitumor Efficacy.

Temperature-Sensitive Nano-GOx Combined with Downregulation of Tumor Stemness to Initiate Robust Antitumor Efficacy.

Journal: ACS nano

Published: March 19, 2025

Screening Natural Cholesterol Analogs to Assemble Self-Adjuvant Lipid Nanoparticles for Antigens Tagging Guided Therapeutic Tumor Vaccine.

Screening Natural Cholesterol Analogs to Assemble Self-Adjuvant Lipid Nanoparticles for Antigens Tagging Guided Therapeutic Tumor Vaccine.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: December 07, 2024

Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment.

Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 28, 2024

Regulating tumor cells to awaken T cell antitumor function and enhance melanoma immunotherapy.

Regulating tumor cells to awaken T cell antitumor function and enhance melanoma immunotherapy.

Journal: Biomaterials

Published: August 24, 2024

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems.

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems.

Journal: ACS nano

Published: July 31, 2024

In situ tumor cell engineering reverses immune escape to enhance immunotherapy effect.

In situ tumor cell engineering reverses immune escape to enhance immunotherapy effect.

Journal: Acta pharmaceutica Sinica. B

Published: May 06, 2024

Treatment of rheumatoid arthritis with curcumin analog 3,5-bis(arylidene)-4-piperidone.

Treatment of rheumatoid arthritis with curcumin analog 3,5-bis(arylidene)-4-piperidone.

Journal: Future medicinal chemistry

Published: November 06, 2023

Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours.

Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours.

Journal: Nature communications

Published: August 22, 2023

In Situ Hydrogel Modulates cDC1-Based Antigen Presentation and Cancer Stemness to Enhance Cancer Vaccine Efficiency.

In Situ Hydrogel Modulates cDC1-Based Antigen Presentation and Cancer Stemness to Enhance Cancer Vaccine Efficiency.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 18, 2023

Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal/chemical/immune synergistic therapy against HCC.

Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal/chemical/immune synergistic therapy against HCC.

Journal: Journal of nanobiotechnology

Published: July 17, 2023

Blockage of HSP90 and IDO1 pathway by α-MSH modified nanoelicitor to dual-facilitate mild photothermal therapy.

Blockage of HSP90 and IDO1 pathway by α-MSH modified nanoelicitor to dual-facilitate mild photothermal therapy.

Journal: Pharmaceutical science advances

Published: June 30, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026